反复种植失败:现实还是统计学幻影?——2022年7月1日卢加诺反复种植失败研讨会共识声明
2022年7月1日国际生殖医学专家在瑞士卢加诺开会,系统综述2015年1月至2022年5月英文文献,认为反复种植失败被过度评估、诊断和治疗,真正反复种植失败在不孕夫妇中不足5%,多数辅助生殖技术失败病例应给予 reassurance 并继续常规治疗,至少3次整倍体囊胚移植失败(或按年龄校正的等效未筛查胚胎移植数)前不应诊断。
要点
- 真正反复种植失败极罕见,在不孕夫妇中不足5%。
- 多数辅助生殖技术失败病例给予 reassurance 并继续常规治疗是合理的。
- 至少3次整倍体囊胚移植失败(或按年龄校正的等效未筛查胚胎移植数)前不应诊断反复种植失败。
核心结论
- 真正反复种植失败极罕见,在不孕夫妇中不足5%,多数病例给予 reassurance 并继续常规治疗是合理的。
- 至少3次整倍体囊胚移植失败(或按年龄校正的等效未筛查胚胎移植数)前不应诊断反复种植失败。
研究设计与样本
- 2022年7月1日国际生殖医学专家在瑞士卢加诺开会,基于2015年1月至2022年5月英文文献的系统综述(未做 Meta 分析)形成共识声明。
主要发现
- 反复种植失败被过度评估、过度诊断和过度治疗,缺乏对真正本质的充分批判性评估。
- 真正反复种植失败在不孕夫妇中不足5%。
- 真正生物学决定因素可能存在于小部分不孕人群中,但现有评估工具无法识别。
- 辅助生殖技术失败可能由多个非重复或非持续因素导致,种植失败不应是唯一考虑的问题。
关键数值与推荐
- 至少3次整倍体囊胚移植失败(或按患者年龄和相应整倍体率校正的等效未筛查胚胎移植数)前不应诊断反复种植失败。
- 诊断前应排除其他可能导致持续种植几率降低的因素。
临床怎么用
- 多数辅助生殖技术失败病例可给予 reassurance 并继续常规治疗。
- 至少3次整倍体囊胚移植失败(或按年龄校正的等效未筛查胚胎移植数)前不应诊断反复种植失败,并应排除其他降低持续种植几率的因素。
局限性
- 文献综述未做 Meta 分析。
- 真正反复种植失败的生物学决定因素可能存在于小部分不孕人群中,但现有评估工具无法识别。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: To date, recurrent implantation failure (RIF) has no clear definition and no clearly identified impaired function. Hence, the term RIF is currently used somewhat haphazardly, on the basis of clinicians' judgment. OBJECTIVE: International experts in reproductive medicine met on July 1, 2022, in Lugano, Switzerland, to review the different facets of RIF and define the diagnosis and its appropriate management. EVIDENCE REVIEW: A systematic review without meta-analysis of studies published in English from January 2015 to May 2022. FINDINGS: Data indicated that RIF has been largely overevaluated, overdiagnosed, and overtreated without sufficient critical assessment of its true nature. Our analyses show that true RIF is extremely uncommon-occurring in <5% of couples with infertility-and that reassurance and continued conventional therapies are warranted in most cases of assisted reproductive technology (ART) failure. Although the true biologic determinants of RIF may exist in a small subset of people with infertility, they elude the currently available tools for assessment. Without identification of the true underlying etiology(ies), it is reasonable not to assign this diagnosis to a patient until she has failed at least 3 euploid blastocyst transfers (or the equivalent number of unscreened embryo transfers, adjusted to the patient's age and corresponding euploidy rate). In addition, other factors should be ruled out that may contribute to her reduced odds of sustained implantation. In such cases, implantation failure should not be the only issue considered in case of ART failure because this may result from multiple other factors that are not necessarily repetitive or persistent. In reality, RIF impacting the probability of further ART success is a very rare occurrence. CONCLUSION: True RIF is extremely uncommon, occurring in <5% of couples with infertility. Reassurance and continued conventional therapies are warranted in most cases. It would seem reasonable not to assign this diagnosis to a patient until she has failed at least 3 euploid embryo transfers (or the equivalent number of unscreened embryos, adjusted to her age). RELEVANCE: Given the number of internationally recognized experts in the field present at the Lugano meeting 2022, our publication constitutes a consensus statement.
引用
- Pirtea P, Cedars MI, Devine K, et al. Recurrent implantation failure: reality or a statistical mirage?: Consensus statement from the July 1, 2022 Lugano Workshop on recurrent implantation failure. Fertil Steril. 2023. PMID: 36822566. doi:10.1016/j.fertnstert.2023.02.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。